Most organizations can afford a 10% efficiency cut, providing immediate financial relief, but how these cuts are done often ...
Biogen, Eisai’s Leqembi Suffers Overseas Setbacks as UK Denies Coverage, Australia Denies Approval
Days after suffering a rejection in Australia, the Alzheimer’s drug hit another roadblock in the U.K., which found the drug ...
In a report released yesterday, William Pickering from Bernstein maintained a Hold rating on Biogen (BIIB – Research Report), with a price ...
In a report released today, David Amsellem from Piper Sandler maintained a Hold rating on Biogen (BIIB – Research Report), with a price target ...
Mark Crossley, who has been with Indivior for a decade and spent much of the last five years as chief exec, will step down ...
Along with Nutley-based Eisai, several other New Jersey-based giants in the space have conducted layoffs over the past few ...
The European Union's medicines regulator on Friday reiterated its positive recommendation for Eisai and Biogen's Alzheimer's ...
Hosted on MSN18d
Biogen Inc. (BIIB): Among the Cheap Pharmaceutical Stocks to Buy According to AnalystsWe recently compiled a list of the 10 Cheap Pharmaceutical Stocks to Buy According to Analysts. In this article, we are going to take a look at where Biogen Inc. (NASDAQ:BIIB) stands against the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback